ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1274

Comparing Performance-Based Measures and Self-Reported Questionnaires for Assessment of Executive Function for Youth with Childhood-Onset Systemic Lupus Erythematosus

Tala El Tal1, Jida Jaffan2, Justine Ledochowski3, Louise Boulard4, Oscar Mwizerwa2, Busisiwe Zapparoli5, Sarah Mossad6, Victoria Lishak7, Ibrahim Mohamed8, Joanna Law9, Lawrence Ng3, Paris Moaf9, Asha Jeyanathan2, Adrienne Davis10, Linda Hiraki3, Deborah Levy3, Ashley Danguecan11 and Andrea Knight12, 1The Hospital For Sick Children & Children's Hospital of Eastern Ontario (CHEO), Ottawa, ON, The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 2The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, The Hospital for Sick Children, Neurosciences and Mental Health, Research Institute, Toronto, ON, Canada, 3The Hospital for Sick Children, Toronto, ON, Canada, 4Neurosciences and Mental Health Program, SickKids Research Institute; The Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 5The Hospital for Sick Children, Etobicoke, ON, Canada, 6Hospital for Sick Children, Toronto, ON, Canada, 7The Hospital for Sick Kids, Toronto, ON, Canada, 8The Hospital for Sick Children, Neurosciences and Mental Health, Research Institute, Toronto, ON, Canada, 9The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 10Division of Pediatric Emergency Medicine, Department of Pediatrics, Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, 11The Hospital for Sick Children, Department of Psychology, University of Toronto, Toronto, ON, Canada, 12Division of Rheumatology, The Hospital for Sick Children; Neurosciences and Mental Health, SickKids Research Institute; Department of Paediatrics, University of Toronto, Toronto, ON, Canada

Meeting: ACR Convergence 2024

Keywords: Cognitive dysfunction, Patient reported outcomes, Pediatric rheumatology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Pediatric Rheumatology – Clinical Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Executive dysfunction is common in childhood-onset systemic lupus erythematosus (cSLE). Comprehensive neuropsychological assessments use both performance-based measures and standardized questionnaires, capturing different cognitive constructs. However, comprehensive assessments are time-consuming, resource-intensive, and often inaccessible.  Standardized questionnaires measuring self-rated daily executive function (EF), are brief and easy to administer, with potential clinical utility to identify patients needing comprehensive assessment. The study aimed to examine associations between performance-based measures and self-rating of daily EF in youth with cSLE. 

Methods: This cross-sectional study analyzed prospectively collected data from cSLE patients (meeting ACR 1997 or SLICC classification criteria) aged 11-17 years recruited from an outpatient Lupus Clinic from January 2020–December 2023, and age and sex-matched healthy controls. Participants completed the Behaviour Rating Inventory of Executive Function 2nd Edition Self-Report Form (BRIEF-2-SR) assessing daily EF measured by the General Executive Composite (GEC), Behavior Regulation Index (BRI), Cognitive Regulation Index (CRI), and Emotion Regulation Index (ERI). The Delis-Kaplan Executive Function System (D-KEFS) Color-Word Interference Test (CWIT), a performance-based measure, assessed information processing speed (Colour Naming, Word Reading), cognitive inhibition and flexibility (Inhibition, Inhibition/Switching). Correlations were calculated between the BRIEF-2-SR summary scores (GEC, BRI, CRI, and ERI) and scaled scores for performance in the four tasks of the D-KEFS CWIT.  Mann-Whitney U tests were used to examine group differences in scores.

Results: There was a total of 58 cSLE participants (84% female; mean age=15.3y ± SD 1.7) and 47 controls (83% female; mean age=14.9y ± SD 1.9) (Table1). For cSLE participants, worse performance-based scores for cognitive inhibition and flexibility showed statistically significantly correlations with worse self-rated daily EF scores for the GEC, BRI, and ERI (Figure 1). For controls, worse scores for cognitive inhibition and flexibility correlated with worse self-rated daily EF scores for GEC and CRI (Figure 1). Performance-based processing speed scores were not significantly associated with the BRIEF-2 scores in either group. No significant differences were found between cSLE and controls across BRIEF-2-SR indices. On the D-KEFS, cSLE participants displayed significantly poorer performance on Color Naming (U = 1027, p = 0.022), Inhibition (U = 1027, p = 0.021), and Inhibition/Switching (U = 1049, p = 0.030) compared to controls.

Conclusion: Youth with cSLE in this cohort had worse performance-based EF measures compared to controls. Performance-based scores for cognitive inhibition and flexibility correlated with self-rated daily EF scores in both groups, but more consistently across indices in the cSLE group. Further study is needed to determine the utility of questionnaires for self-rated daily EF as efficient screening tools to identify cSLE patients needing comprehensive neuropsychological assessment.

Supporting image 1

Supporting image 2

Figure 1: Spearman Rho correlation matrices depicting the associations between BRIEF_2-SR (higher scores indicating worse executive function) and D-KEFS (lower scores indicating worse executive function) measures for childhood-onset systemic lupus erythematosus (cSLE) participants and controls. * Denotes significance (p < 0.05)


Disclosures: T. El Tal: None; J. Jaffan: None; J. Ledochowski: None; L. Boulard: None; O. Mwizerwa: None; B. Zapparoli: None; S. Mossad: None; V. Lishak: None; I. Mohamed: None; J. Law: None; L. Ng: None; P. Moaf: None; A. Jeyanathan: None; A. Davis: None; L. Hiraki: Janssen, 2; D. Levy: AbbVie, 5, AstraZeneca, 5, Roche, 5, SOBI, 5; A. Danguecan: None; A. Knight: Pfizer, 6.

To cite this abstract in AMA style:

El Tal T, Jaffan J, Ledochowski J, Boulard L, Mwizerwa O, Zapparoli B, Mossad S, Lishak V, Mohamed I, Law J, Ng L, Moaf P, Jeyanathan A, Davis A, Hiraki L, Levy D, Danguecan A, Knight A. Comparing Performance-Based Measures and Self-Reported Questionnaires for Assessment of Executive Function for Youth with Childhood-Onset Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/comparing-performance-based-measures-and-self-reported-questionnaires-for-assessment-of-executive-function-for-youth-with-childhood-onset-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparing-performance-based-measures-and-self-reported-questionnaires-for-assessment-of-executive-function-for-youth-with-childhood-onset-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology